Moleculin Biotech (MBRX) Current Leases (2019 - 2022)
Moleculin Biotech (MBRX) posted quarterly Current Leases of $116000.0 for Q4 2022, up 20.83% year-over-year from $96000.0 in Q4 2021, and up 3.57% quarter-over-quarter from $112000.0 in Q3 2022.
Moleculin Biotech (MBRX) Current Leases (2019 - 2022) Analysis & Trends
Moleculin Biotech's Current Leases history runs 4 years deep, the most recent figure standing at $116000.0 for Q4 2022.
- In Q4 2022, Current Leases rose 20.83% year-over-year to $116000.0; the TTM figure through Dec 2022 stood at $116000.0 (up 20.83% YoY), while the FY2022 annual figure was $116000.0, up 20.83% from the prior year.
- Current Leases for Q4 2022 stood at $116000.0, up from $112000.0 in the prior quarter.
- The five-year high for Current Leases was $122000.0 in Q1 2021, with the low at $77000.0 in Q1 2022.
- The 4-year median for Current Leases is $112000.0 (2022), against an average of $106222.2.
- Peak annual rise in Current Leases reached 20.83% in 2022, while the deepest fall reached 36.89% in 2022.
- Moleculin Biotech's Current Leases stood at $103000.0 in 2019, then advanced by 14.56% to $118000.0 in 2020, then declined by 18.64% to $96000.0 in 2021, then increased by 20.83% to $116000.0 in 2022.
- Business Quant data shows MBRX's Current Leases at $116000.0 in Q4 2022, $112000.0 in Q3 2022, and $98000.0 in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 45.93 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 6.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | - |
| 10 | Moleculin Biotech | 3.35 Mn | 3.35 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 116,000.00 |
| Sep 30, 2022 | 112,000.00 |
| Jun 30, 2022 | 98,000.00 |
| Mar 31, 2022 | 77,000.00 |
| Dec 31, 2021 | 96,000.00 |
| Mar 31, 2021 | 122,000.00 |
| Dec 31, 2020 | 118,000.00 |
| Sep 30, 2020 | 114,000.00 |
| Dec 31, 2019 | 103,000.00 |